PROCEPT BioRobotics Corp (PRCT)

82.01 -1.52 (-1.82%) USD  |  NASDAQ  |  Dec 27, 16:00
82.13 +0.12 (+0.15%) After-Hours: 20:00
More

PROCEPT BioRobotics Research and Development Expense (Quarterly): 16.65M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for PRCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp 407.00M
Intuitive Surgical Inc 286.00M
Teleflex Inc 38.73M
RxSight Inc 8.838M
Perspective Therapeutics Inc 12.03M